Why pharmaceutical companies need to move beyond therapies and embrace total care solutions
As is the case with many emerging technologies, we’re now in the early stages of defining consensus and understanding around what digital therapeutics (DTx) are and how they work.
For Pharmas to realize the full potential digital therapeutics, they need to take a much more comprehensive view of conditions and problems that HCPs and people suffering from disease and chronicconditions face.
Download the Report to learn more about:
Moving from discrete therapies to holistic care solutions
Identifying and understanding the latest in digital therapies and products
How to utilize human-centered design to find new opportunities in this developing market
frog is a global design and innovation consultancy. For 50 years we have helped organizations envision bold futures and design, build and scale innovative new businesses and consumer experiences.